# Bangladesh Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Bangladesh HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Bangladesh (BGD)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $60.5M
- Products: 24
- Buyer markets: 31
- Average CAGR: +15.2%
- Global sector size: $458.2B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $307.8B | $25.7M | $115.4B | +8.2% | 24 | +0.0% |
| HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $9.3B | $336.5 | $11.3B | -10.9% | 2 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $16.1B | $75.0K | $11.2B | +50.6% | 4 | +0.1% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $17.6B | $20.8M | $10.6B | +41.6% | 8 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $21.3B | $4.2K | $9.8B | -5.0% | 7 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $20.4B | $259.7K | $8.8B | -16.8% | 5 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $15.7B | $1.4K | $8.4B | +38.5% | 3 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $10.8B | $46.1K | $6.5B | +12.0% | 5 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $6.4B | $954.8K | $4.6B | +79.8% | 3 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $8.0B | $168.3 | $2.9B | +37.9% | 1 | +0.0% |
| HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $2.0B | $8.4M | $2.9B | +28.3% | 2 | +0.3% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $2.3B | $3.4K | $2.1B | +6.4% | 2 | +0.0% |
| HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $5.5K | $2.0B | -5.1% | 1 | +0.0% |
| HS 370790 - Photographic goods: chemical preparations other than sensitised emulsions, put up in measured portions or put up for retail sale in a form ready for use | $2.2B | $817.3 | $1.8B | +64.5% | 1 | +0.0% |
| HS 293590 - Sulphonamides: n.e.c. in heading no. 2935 | $1.1B | $55.1 | $1.4B | -70.2% | 1 | +0.0% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $275.0 | $1.4B | -2.2% | 1 | +0.0% |
| HS 321590 - Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $674.3M | $79.7 | $1.1B | -2.9% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $2.7B | $4.7K | $1.0B | +73.2% | 1 | +0.0% |
| HS 310210 - Fertilizers, mineral or chemical: nitrogenous, urea, whether or not in aqueous solution | $2.0B | $4.0M | $1.0B | -8.2% | 1 | +0.2% |
| HS 320611 - Colouring matter: pigments and preparations based on titanium dioxide, containing 80% or more by weight of titanium dioxide calculated on the dry matter | $1.1B | $14.7 | $997.2M | -49.7% | 1 | +0.0% |
| HS 294190 - Antibiotics: n.e.c. in heading no. 2941 | $883.6M | $14.7K | $990.0M | +26.4% | 1 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $2.0B | $25.0 | $981.1M | -32.3% | 1 | +0.0% |
| HS 300449 - Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale | $1.5B | $199.9K | $841.2M | +46.0% | 1 | +0.0% |
| HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.3B | $9.8K | $803.3M | +33.9% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $40.9B calculated opportunity across 9 products.
- Switzerland, Liechtenstein (CHE): $33.9B calculated opportunity across 3 products.
- Slovenia (SVN): $20.3B calculated opportunity across 2 products.
- China (CHN): $17.9B calculated opportunity across 7 products.
- Germany (DEU): $11.3B calculated opportunity across 6 products.
- Spain (ESP): $9.2B calculated opportunity across 4 products.
- Canada (CAN): $9.1B calculated opportunity across 6 products.
- Belgium (BEL): $7.9B calculated opportunity across 2 products.
- France (FRA): $7.4B calculated opportunity across 5 products.
- United Kingdom (GBR): $7.1B calculated opportunity across 4 products.
- India (IND): $5.8B calculated opportunity across 6 products.
- Italy (ITA): $5.6B calculated opportunity across 2 products.

## Growth stars

- HS 300439: +79.8% average CAGR, $4.6B calculated opportunity.
- HS 300290: +73.2% average CAGR, $1.0B calculated opportunity.
- HS 370790: +64.5% average CAGR, $1.8B calculated opportunity.
- HS 300220: +50.6% average CAGR, $11.2B calculated opportunity.
- HS 300449: +46.0% average CAGR, $841.2M calculated opportunity.
- HS 382499: +41.6% average CAGR, $10.6B calculated opportunity.
- HS 300212: +38.5% average CAGR, $8.4B calculated opportunity.
- HS 300215: +37.9% average CAGR, $2.9B calculated opportunity.
- HS 330290: +33.9% average CAGR, $803.3M calculated opportunity.
- HS 382319: +28.3% average CAGR, $2.9B calculated opportunity.

## Diversification opportunities

- HS 300490: 24 buyer markets, $115.4B calculated opportunity.
- HS 382499: 8 buyer markets, $10.6B calculated opportunity.
- HS 382200: 7 buyer markets, $9.8B calculated opportunity.
- HS 330499: 5 buyer markets, $8.8B calculated opportunity.
- HS 330300: 5 buyer markets, $6.5B calculated opportunity.
- HS 300220: 4 buyer markets, $11.2B calculated opportunity.
- HS 300212: 3 buyer markets, $8.4B calculated opportunity.
- HS 300439: 3 buyer markets, $4.6B calculated opportunity.
- HS 293399: 2 buyer markets, $11.3B calculated opportunity.
- HS 382319: 2 buyer markets, $2.9B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.